Exome sequencing deciphers rare diseases

Area of Science:

• Genomic Medicine
• Rare Disease Diagnosis
• Clinical Genomics

Background:

• The National Institutes of Health (NIH) Undiagnosed Diseases Program (UDP) was established to address the diagnostic challenges in rare diseases.
• Genomic technologies offer powerful tools for diagnosing conditions that have remained elusive through traditional methods.

Purpose of the Study:

• To evaluate the impact and success of implementing large-scale exome sequencing within a clinical setting.
• To demonstrate the diagnostic yield of genomics for patients with undiagnosed rare diseases.
• To highlight advancements in managing and interpreting large volumes of genomic data.

Main Methods:

• Whole exome sequencing was performed on a cohort of patients with undiagnosed diseases.
• Genomic data analysis pipelines were developed and applied for variant identification and interpretation.
• Clinical correlation of identified genetic variants was conducted to establish diagnoses.

Main Results:

• Sequencing of 128 exomes led to the diagnosis of 39 rare diseases.
• The program demonstrated a significant diagnostic success rate, improving patient outcomes.
• New methods for managing the "tsunami" of genomic data were pioneered.

Conclusions:

• Large-scale clinical genomics, particularly whole exome sequencing, is effective for diagnosing rare diseases.
• The NIH UDP's success provides a model for integrating genomics into routine clinical practice.
• Continued innovation in genomic data analysis and management is crucial for the future of personal genomics.